Adaptive Biotechnologies director Peter M. Neupert disposes of 124,690 common shares for $3.14 million
Reuters2026/08/20 00:08- Adaptive Biotechnologies director Peter M. Neupert reported option exercise and share sales dated Aug. 17, 2026.
- Exercised 15,000 stock options at $6.32, then sold 124,690 shares at weighted-average prices near $25.10-$25.23.
- Directly held 130,625 shares following the transactions.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Robinhood Chain hits record $989 million in daily DEX volume as TVL grows
The weakening US dollar sparks a surge in carry trades, and emerging markets are about to face a “capital tsunami.”
Analysts pointed out that the US Treasury’s bond repurchase plan has weakened the US dollar, and investors seeking new opportunities may drive capital inflows into emerging markets.
After 30 years, Japan’s 10-year government bond yield returns to 3%, breaking the major shackles of the “zero interest rate era”
Japan’s 10-year government bond yield briefly rose to 3% on Tuesday, marking the first time this has occurred in the 21st century. This milestone signals an important step in the normalization process for the country's bond market, after years of benchmark borrowing costs hovering around zero.
Cerebras (CBRS.US) builds a new 165-megawatt AI data center in Finland, accelerating its computing power expansion in Europe
Cerebras Systems announced on Tuesday the establishment of a new AI data center in Mikkeli, Finland.
Crypto prices
More
